We employ an extremely skilled and talented team with strong scientific competence and expertise in analytical technologies (LC/MS and NMR), in order to guarantee high scientific and technical data quality for our customers.

Dr. Ari Tolonen

CEO & Senior Scientist Metabolism

Dr. Ari Tolonen


Dr. Ari Tolonen has more than a decade of experience as a head of ADME CRO laboratory, with a top expertise in drug metabolism, drug-drug-interactions, metabolite identification & profiling, and quantitative bioanalysis. During his career Ari has planned & directed more than 1000 ADME studies to >150 customer companies. He has contributed >50 peer reviewed scientific papers, review articles & book chapters in the field of drug metabolism, metabolite profiling & identification, quantitative bioanalysis, and LC/MS techniques.

Dr. Juho Hokkanen

COO & Senior Scientist Bioanalysis


Dr. Juho Hokkanen has a long experience in CRO-business, with a special expertise in drug metabolism, drug-drug interactions and quantitative bioanalysis. He has contributed to >10 peer reviewed original scientific papers in the field of drug metabolism, quantitative bioanalysis, LC/MS techniques and natural product analysis.

Dr. Aki Heikkinen

Senior Scientist Drug-Drug Interactions and PBPK


Dr. Aki Heikkinen has worked in the pharma industry in Switzerland as a Roche Postdoc Fellow and has also gained several years of experience in drug research in academic settings. His expertise lies in in vitro to in vivo extrapolation, physiologically based pharmacokinetic modelling (PBPK), and transporter and metabolism based drug-drug interactions (DDI). Aki has contributed to >15 peer reviewed research, review articles and book chapters.

Dr. Sanna-Mari Aatsinki

Senior Scientist Drug-Drug Interactions


Currently on maternity leave. Dr. Sanna-Mari Aatsinki has several years of experience in research related to regulation of drug-metabolising CYP enzymes as well as hepatic cell signaling pathways. Her expertise lies within various cell-based assays and mRNA analysis techniques. She has also contributed to many peer reviewed scientific papers.

Dr. Janne Mannila

Senior Scientist Permeability and in vivo DMPK

Dr. Janne Mannila has an extensive knowledge in the field of in vivo and in vitro pharmacokinetics as well as preclinical formulation design and permeability studies. He joined Admescope after an eight year period in Australia at another preclinical CRO. Janne has contributed to >15 peer reviewed research papers, book chapters and international patents.

Dr. Minna Komu

Senior Scientist in vitro Toxicology

Dr. Minna Komu’s scientific background is in different research groups in Finland and USA. She has also contributed to many peer reviewed scientific research and review articles, including publications in several high-profile journals, such as Nature. Minna's expertise lies in various cell-based assays, organ culture, mRNA analysis techniques and in vivo work.

Juho Alatalo

Vice President, Sales and Marketing

Juho Alatalo kuva

Juho Alatalo has over 15 years’ experience of international sales and marketing across different industries. His educational background is in Economics, from which he holds a Master’s degree in Marketing. Juho joined Admescope upon his return from an expatriate assignment in Berlin, Germany, where he was stationed as the business director for Siili Solutions, a Finnish software company. He has also previously worked for Pfizer, contributing as a member of the Specialty Care Leadership team in Finland.